Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 875,500 | 414,700 | 321,400 | 263,800 | 254,000 |
| Income taxes - deferred | -96,500 | -167,000 | -16,600 | 1,200 | -132,200 |
| Accounts receivable | -265,000 | -263,100 | -298,400 | -194,700 | -52,000 |
| Other Working Capital | 564,400 | 7,800 | -54,100 | 41,100 | 228,000 |
| Other Operating Activity | 3,061,500 | 3,056,100 | 2,552,100 | 2,322,600 | 1,757,800 |
| Operating Cash Flow | $4,139,900 | $3,048,500 | $2,504,400 | $2,434,000 | $2,055,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,009,300 | -1,012,700 | -1,066,600 | -1,041,500 | -670,800 |
| Purchase Of Investment | -14,814,500 | -9,521,400 | -5,255,800 | -8,800,600 | -8,563,300 |
| Sale Of Investment | 15,082,300 | 9,863,500 | 4,983,100 | 8,518,900 | 8,227,600 |
| Other Investing Activity | 709,100 | -1,917,100 | -12,600 | 22,600 | 6,700 |
| Investing Cash Flow | $-32,400 | $-2,587,700 | $-1,351,900 | $-1,300,600 | $-999,800 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 138,600 | 83,400 | 52,200 | 48,300 | 37,800 |
| Common Stock Repurchased | -704,500 | -371,000 | -862,900 | -184,100 | -744,800 |
| Dividend Paid | -1,434,100 | -1,174,400 | -1,064,300 | -893,200 | -749,400 |
| Other Financing Activity | -1,402,200 | 1,247,800 | 519,700 | -109,100 | 502,700 |
| Financing Cash Flow | $-3,402,200 | $-214,200 | $-1,355,300 | $-1,138,100 | $-953,700 |
| Exchange Rate Effect | 69,300 | 7,700 | -20,000 | -3,800 | 19,200 |
| Beginning Cash Position | 829,400 | 575,100 | 797,900 | 806,400 | 685,100 |
| End Cash Position | 1,604,000 | 829,400 | 0 | 0 | 0 |
| Net Cash Flow | $705,300 | $246,600 | $-202,800 | $-4,700 | $102,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,139,900 | 3,048,500 | 2,504,400 | 2,434,000 | 2,055,600 |
| Capital Expenditure | -1,009,300 | -1,012,700 | -1,066,600 | -1,041,500 | -670,800 |
| Free Cash Flow | 3,130,600 | 2,035,800 | 1,437,800 | 1,392,500 | 1,384,800 |